Shift Bioscience

Developer of drugs that reprogram mitochondrial (mtDNA) mutations

placeLetchworth Garden City, England, United Kingdom calendar_todayFounded 2017 groups3 employees language shiftbioscience.com

Registered entities

Innovation

34 patent families — focus: Physics & computing, Chemistry & metallurgy; filing pace accelerating. Cited 35 times.

YearFilings
20182
20192
20202
20211
20232
202420
20256

Investor mix

19 investors on record; lead investors include BGF.

Investor typeCountShare
Venture capital632%
Private equity15%
Other / undisclosed1263%
Coming soon